Financials DBV Technologies

Equities

DBV

FR0010417345

Pharmaceuticals

Real-time Euronext Paris 03:42:35 2024-06-18 EDT 5-day change 1st Jan Change
0.965 EUR +1.26% Intraday chart for DBV Technologies -3.02% -47.81%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 922.4 237.7 168.2 295.6 178 91.71 - -
Enterprise Value (EV) 1 774.5 73.75 98.88 98.35 48.63 -53.4 -24.75 -25.39
P/E ratio -2.37 x -0.88 x -0.94 x -1.35 x -1.33 x - - -
Yield - - - - - - - -
Capitalization / Revenue 70.4 x 25.2 x 32.6 x 65.3 x 12.4 x 15.3 x 17 x 3.82 x
EV / Revenue 59.1 x 7.83 x 19.1 x 21.7 x 3.38 x -8.89 x -4.59 x -1.06 x
EV / EBITDA -5.21 x -0.71 x -1.2 x -1.25 x -0.59 x 0.43 x 0.19 x 0.27 x
EV / FCF -5.8 x -0.52 x -1.01 x -1.85 x -1.03 x 0.34 x 0.14 x 0.14 x
FCF Yield -17.2% -192% -99.1% -54.1% -97.5% 294% 705% 696%
Price to Book 2.12 x 0.68 x 0.94 x 0.81 x 0.69 x - - -
Nbr of stocks (in thousands) 46,987 54,815 54,983 93,967 96,256 96,230 - -
Reference price 2 19.63 4.336 3.059 3.146 1.849 0.9530 0.9530 0.9530
Announcement Date 20-03-04 21-03-11 22-03-03 23-03-02 24-03-07 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 13.1 9.424 5.165 4.526 14.39 6.009 5.398 24
EBITDA 1 -148.8 -104.4 -82.28 -78.71 -82.74 -123.7 -127.6 -95.42
EBIT 1 -151.7 -112.6 -89.75 -90.72 -69.94 -131.8 -136 -122.5
Operating Margin -1,158.02% -1,194.25% -1,737.63% -2,004.17% -485.96% -2,192.98% -2,519.33% -510.49%
Earnings before Tax (EBT) 1 -153 -133.2 -144.5 -90.43 -66.54 -130 -135.8 -114
Net income 1 -153.6 -133.2 -144.5 -90.53 -66.54 -126.3 -122.7 -111
Net margin -1,172.52% -1,413.39% -2,797.21% -2,000% -462.4% -2,101.17% -2,273.37% -462.21%
EPS -8.300 -4.931 -3.240 -2.339 -1.391 - - -
Free Cash Flow 1 -133.5 -141.5 -97.98 -53.2 -47.43 -156.9 -174.5 -176.7
FCF margin -1,019.02% -1,500.93% -1,896.99% -1,175.25% -329.59% -2,610.55% -3,232.54% -736.26%
FCF Conversion (EBITDA) - - - - - - - -
FCF Conversion (Net income) - - - - - - - -
Dividend per Share - - - - - - - -
Announcement Date 20-03-04 21-03-11 22-03-03 23-03-02 24-03-07 - - -
1EUR in Million
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2019 S2 2020 S1 2020 S2 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 6.038 7.6 4.067 2.653 2.423 1.488 2.125 -1.271 1.999 2.087 2.272 8.121 1.299 1.563 1.567 1.572 1.237
EBITDA - - - - - - - - - - - - - - - - -
EBIT 1 -72.37 -66.58 -44.72 -12.71 -15.96 -23.19 -18.46 -35.44 -19.18 -22.68 -17.23 -10.91 -26.9 -31.59 -35.39 -39.43 -35.64
Operating Margin -1,198.63% -876.05% -1,099.59% -479.13% -658.72% -1,558.08% -868.85% 2,788.29% -959.09% -1,086.96% -758.33% -134.31% -2,071.43% -2,021.21% -2,257.83% -2,508.35% -2,880.76%
Earnings before Tax (EBT) 1 -73.24 -86.54 -44.97 -68.35 -15.82 -22.43 -17.71 -36.73 -18.63 -21.96 -15.81 -10.24 -25.33 -31.22 -36.92 -43.92 -
Net income 1 -73.79 -86.5 -44.96 -68.35 -15.9 -22.43 -17.71 -36.75 -18.63 -21.96 -15.81 -10.24 -25.33 -29.43 -33.47 -38.15 -
Net margin -1,222.09% -1,138.16% -1,105.58% -2,576.02% -656.17% -1,506.8% -833.51% 2,890.74% -931.82% -1,052.17% -695.83% -126.04% -1,950% -1,883% -2,135.11% -2,426.6% -
EPS - - - -0.4694 -0.5711 -0.6814 -0.3689 -0.8487 -0.3999 -0.4718 -0.3218 -0.2013 -0.5195 - - - -
Dividend per Share - - - - - - - - - - - - - - - - -
Announcement Date 20-03-04 20-07-31 21-03-11 22-03-03 22-05-02 22-08-01 22-11-03 23-03-02 23-05-04 23-07-31 23-10-31 24-03-07 24-05-07 - - - -
1EUR in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - - - -
Net Cash position 1 148 164 69.3 197 129 145 116 117
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 -133 -141 -98 -53.2 -47.4 -157 -174 -177
ROE (net income / shareholders' equity) -105% -80% -105% -65.6% -43.5% - - -
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share 9.270 6.380 3.260 3.900 2.670 - - -
Cash Flow per Share 2 -6.950 -5.150 -3.560 -1.360 -0.9800 -1.200 -1.200 -1.290
Capex 1 4.97 2.3 0.28 0.09 0.62 21.8 25 28.7
Capex / Sales 37.96% 24.36% 5.49% 2.08% 4.3% 362.65% 462.88% 119.36%
Announcement Date 20-03-04 21-03-11 22-03-03 23-03-02 24-03-07 - - -
1EUR in Million2EUR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
0.953 EUR
Average target price
4.4 EUR
Spread / Average Target
+361.70%
Consensus
  1. Stock Market
  2. Equities
  3. DBV Stock
  4. Financials DBV Technologies